Related Experiment Video
Updated: Mar 15, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Coumarin and Derivates as Lipid Lowering Agents
Silvia Tejada, Miquel Martorell, Xavier Capo
1Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, Ctra. Valldemossa, km 7.5, E-07122 - Palma de Mallorca, Balearic Islands, Spain.
Insights
Coumarin compounds show promise in lowering lipids and reducing oxidative stress, offering potential therapeutic benefits for cardiovascular disease. This review explores their role in managing dyslipidemia and preventing heart conditions.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Medicine
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality in developed nations.
- Dyslipidemia, characterized by abnormal blood lipid levels, is a significant risk factor for CVD.
- Oxidative stress is implicated in the development of various diseases, including CVD.
Purpose of the Study:
- To review the available reports on the lipid-lowering and antioxidant effects of coumarin and its derivatives.
- To explore the potential therapeutic and preventive roles of coumarin compounds in managing dyslipidemia and CVD.
Main Methods:
- Literature review of scientific reports and studies.
- Analysis of pharmacological activities of coumarin and its derivatives.
- Focus on antioxidant and lipid-lowering properties.
Main Results:
- Coumarin, a natural phenolic compound, exhibits promising lipid-lowering effects.
- Coumarin derivatives possess broad pharmacological activities, including antioxidant and vasodilator effects.
- Evidence suggests a beneficial role for coumarin compounds in managing dyslipidemia.
Conclusions:
- Coumarin and its derivatives demonstrate potential as therapeutic agents for dyslipidemia.
- The antioxidant and lipid-lowering properties of coumarin compounds warrant further investigation for CVD prevention.
- Natural compounds like coumarin offer a promising avenue for managing cardiovascular risk factors.
Abstract:
Cardiovascular disease is the main cause of death in the developed countries. Dyslipidaemia is one of the risk factors associated to cardiovascular disease and it is characterised by abnormal amounts of lipids (i.e. cholesterol and fatty acids) and/or circulating lipoproteins in the blood. Oxidative stress has been implicated in the pathogenesis of various illnesses including cardiovascular disease. In this way, the potential therapeutic or preventive effects of antioxidant mediators have recently drawn much attention. Coumarin (1,2-benzopyrone) is a natural phenolic compound found in many plants such as citrus fruits, tomatoes, vegetables and green tea. Coumarin and derivates are proposed as lipid lowering agents due to its broad pharmacological activities, mainly the implicated in vasodilator and antioxidant effect. Several studies have evidenced a promising role of coumarin and several of its derivates as lipid lowering agents. In the current work, the available reports related to the promising function of these compounds are reviewed.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Atherosclerosis III: Management
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Antihypertensive Drugs: Direct Renin Inhibitors
Cholesterol: Significance and Regulation
Considering cholesterol and...

